New York Mercantile Exchange › CRUDE OIL Aug 2013/Jun 2015 Spread (NYMEX:CL.Q13_M15.E)
7.02 +0.36 (+5.41%)
2013-05-22 17:43:26, 30 min delay
|Contract High Date||2013-05-08|
|Contract Low Date||2013-04-16|
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Stocks edge lower as investors reassess Fed fears
1 hour, 25 minutes ago
This is what I said on CNBC Asia before the crash 8 hours ago
Market sell-off goes on 9 hours ago
Investors Versus Traders: A Battle for Oil & Gas Profits 21 hours ago
1 hour ago
The Food and Drug Administration said Thursday it approved a new blood test from Roche to help doctors diagnose diabetes. Such tests have long been used to monitor blood sugar levels in people with diabetes. The FDA said Roche's test is the first to be approved to diagnose the disease. "Providing health care professionals with another tool to identify undiagnosed cases of diabetes should help them provide patients appropriate guidance on treatment before problems develop," said Alberto Gutierrez, FDA's director of in vitro diagnostic tests
1 hour, 2 minutes ago
A website partially funded by the oil and gas industry could be a "constructive" tool for federal regulators as they consider requiring public disclosure of chemicals used in hydraulic fracturing operations, Senate Energy Committee Chairman Ron Wyden said Thursday. Fracking involves pumping huge volumes of water, sand and chemicals underground to split open rocks to allow oil and gas to flow. Improved technology has allowed energy companies to gain access to huge stores of natural gas underneath states from Wyoming to New York but has raised widespread concerns that it might lead to groundwater contamination and even earthquakes.
1 hour, 4 minutes ago
Royalty Pharma has eased one of its conditions for completing its recently increased offer to buy Irish drugmaker Elan Corp. PLC for $12.50 per share, or about $7.5 billion. Royalty's offer, which it announced Monday, also is contingent on shareholders voting against Elan's recent push to refocus its business.
58 minutes ago
Stocks edge lower; Dow recoups a big early loss as investors reassess Fed stimulus fears Sears reports bigger-than-expected loss for 1st quarter Gap's 1st-quarter net income rises 43 percent on strong sales as turnaround continues